首页> 外国专利> BASICALLY SUBSTITUTED BENZOYLGUANIDINES, PROCESS OF THEIR PREPARATION, THEIR USE FOR PREPARING MEDICAMENT OR A DIAGNOSTIC AGENT CONTAINING SUCH COMPOUNDS

BASICALLY SUBSTITUTED BENZOYLGUANIDINES, PROCESS OF THEIR PREPARATION, THEIR USE FOR PREPARING MEDICAMENT OR A DIAGNOSTIC AGENT CONTAINING SUCH COMPOUNDS

机译:基本取代的苯甲酰二胍,其制备过程,其在制备药物或包含此类化合物的诊断剂中的用途

摘要

Basic substd. benzoylguanidine derivs. of formula (I) and their salts are new. One of R1-R3 = Xf-CdH2d-B-A-R6 and the others of R1-R3 = H, F, Cl, Br, I, CN, 1-8C alkyl, 2-8C alkenyl, NR35R36 or Zh-CgH2g-R17; R6 = NR7R8, C(=NR9)NR7R8, NR10-C(=NR9)NR7R8 or basic heteroaromatic ring system with 1-9C; R7-R10 = H or 1-4C alkyl; or R7+R8 = C4H8 or CaH2a (opt. with one CH2 replaced by O, S(O)m or NR11; or R8+R9+R10 or R7+R10 = C2H4 or CcH2c (opt. with one CH2 replaced by O, S(O)m or NR11); A = CbH2b (opt. with one or two CH2 replaced by O, CO, CH(OR20), S(O)m, NR20, CONR20, NHCONR20, SO2NHCONR20, S(=O)(=NR19)NR20 or SO2NR20, or one CH2 replaced by CHR99); R7+R99 form pyrrolidine or piperidine; B = opt. substd. phenylene or naphthylene gp. of formula (i) or (ii); R12, R13 = H, Me, F, Cl, Br, I, CF3 or S(O)mR14; R14, R19 = H or 1-4C alkyl; X = O, CO, CH(OR21), SOm or NR21; R35, R36 = H or 1-6C alkyl; or R35+R36 = (CH2)4-7, with one CH2 opt. replaced by S, NH, NMe or N-benzyl; Z = O, CO, SOm, NR18, CONR18, NHCONR18 or SO2NR18; R17 = H, cyclopropyl, cyclopentyl, cyclohexyl, 1-3C perfluoroalkyl, 1-, 2- or 3-pyrrolyl (opt. substd. by 1-4 of F, Cl, Br, I, CN, 2-8C alkanoyl, 2-8C alkoxycarbonyl, CHO, COOH, CF3, Me and OMe) or 3-8C cycloalkyl or phenyl (both opt. substd. by 1-3 of F, Cl, CF3, Me, OH, OMe, NR37R38, SO2Me and SO2NH2); R11, R18, R20, R21, R37, R38 = H or Me; R4, R5 = H, 1-4C alkyl, F, Cl, OR32, NR33R34 or 1-4C perfluoroalkyl; R32-R34 = H or 1-3C alkyl; a = 5-7; b = 1-10; c = 3-5; d = 0-5; g = 0-4; f, h = 0 or 1; m = 0-2.
机译:基本替代。苯甲酰胍衍生物。式(I)的化合物及其盐是新的。 R1-R3之一= Xf-CdH2d-BA-R6,R1-R3另一个= H,F,Cl,Br,I,CN,1-8C烷基,2-8C烯基,NR35R36或Zh-CgH2g-R17 ; R6 = NR7R8,C(= NR9)NR7R8,NR10-C(= NR9)NR7R8或具有1-9C的基本杂芳族环系统; R7-R10 = H或1-4C烷基;或R7 + R8 = C4H8或CaH2a(用O,S(O)m或NR11取代一个CH2;或者R8 + R9 + R10或R7 + R10 = C2H4或CcH2c(用O取代一个CH2,而不是S(O)m或NR11); A = CbH2b(使用一或两个CH2替换为O,CO,CH(OR20),S(O)m,NR20,CONR20,NHCONR20,SO2NHCONR20,S(= O) (= NR19)NR20或SO2NR20,或一个CH2被CHR99取代); R7 + R99形成吡咯烷或哌啶; B =式(i)或(ii)的亚苯基或亚萘基; R12,R13 = H ,Me,F,Cl,Br,I,CF3或S(O)mR14; R14,R19 = H或1-4C烷基; X = O,CO,CH(OR21),SOm或NR21; R35,R36 = H或1-6C烷基;或R35 + R36 =(CH2)4-7,其中一个CH2选项被S,NH,NMe或N-苄基取代; Z = O,CO,SOm,NR18,CONR18,NHCONR18或SO2NR18 ; R17 = H,环丙基,环戊基,环己基,1-3C全氟烷基,1-,2-或3-吡咯基(优选由1-4的F,Cl,Br,I,CN,2-8C烷酰基取代, 2-8C烷氧羰基,CHO,COOH,CF3,Me和OMe)或3-8C环烷基或苯基(均被F,Cl,CF3,Me,OH,OMe,NR37R38,SO2Me 1-3取代)和SO2NH2); R11,R18,R20,R21,R37,R38 = H或Me; R4,R5 = H,1-4C烷基,F,Cl,OR32,NR33R34或1-4C全氟烷基; R32-R34 = H或1-3C烷基; a = 5-7; b = 1-10; c = 3-5; d = 0-5; g = 0-4; f,h = 0或1; m = 0-2。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号